|
We asked 40 industry leaders,  Which of these countries do you believe will drive most
of pharma's growth over the next 12 months?
Click here to vote.
| USA |
23% |
China |
36% |
| Brazil |
9% |
| Japan |
3% |
| Germany |
9% |
| India |
26% |
|
|
 |
|
|
|
|
|
30 September, 2014
|
|
|
Trouble Brewing on the European Drug-Pricing Horizon
"Better volcano forecasting", the European Union announced with pride in mid-September. The breakthrough was a new EU-funded monitoring scheme for Iceland's volatile geology. What the EU has paid less attention to is the volcano that is soon likely to blow apart its assumptions on the pricing and reimbursement of medicines, writes our Brussels correspondent Reflector. Read more |
Email Marketing Grows Up
Email marketing is still very much with us, despite much talk of its demise. But, writes Peter Houston, it has moved on from its “spammy” adolescence. This is thanks to its role as the corner-stone of multichannel marketing, a unique identifier at the center of a 360-degree view of the customer... Read more
|
UK Postpones Value-Based Assessment Decision — Again
Value-based pricing (VBP) was first discussed in the UK as far back as 2007. Since then it has been dropped in favor of value-based assessment (VBA). Now, writes Leela Barham, VBA has been kicked into the long grass once more. Leela Barham reports ... Read more
|
Investing in Africa: Study, Share, Act — and Grow
Is sub-Saharan Africa a jewel box of untapped assets for a growth-obsessed big Pharma? Some of the majors apparently think so.” To identify some benchmarks for best practices in building a viable drugs business in Africa, Pharm Exec recently spoke with Steven Adjei, a native Ghanaian and founding partner of an investment advisory firm and start-up business “incubator” focused on opportunities in the sub-Saharan region .... Read more
|
|
|
|
|
